This course gives answers to the question of which regulatory aspects are important throughout the product development cycle. What are the GMP requirements at various stages of product development (research, animal studies, clinical phases I, II & III)?
This training deals with various GMP aspects that are important for the production process of (bio)pharmaceutical products.
This training also discusses the different regulatory standards required during the various phases of product development (development, animal research, clinical phases I, II and III) and how IMP’s are released for the use in clinical trials.
Course time09h00 - 17h00
Who should attend
This training is developed for people who work within an R&D environment (laboratory/ produc-tion) who would like to know more about GMP, for example, to be able to adapt and adjust their development processes in accordance with future demands.
This course is also intended for clinical research professionals to get a better understanding of the manufacturing and analysis of clinical material (Investigational Medicinal Product or IMP).In fact, the training is suited for staff who just want to know more about GMP or work in a pharmaceutical company but have not (yet) worked under GMP conditions.
- The Product life cycle
- R&D regulations
- Risk management in new product development
- Stability and shelf life studies
- Release of IMP’s for clinical trials
- Gaining understanding and knowledge of GMP
- Understanding the importance of process flows and structures within the GMP system
- Understanding GMP related to the manufacturing and testing and how this relates to the activities performed in the clinic with that material.